Research and Publication Committee

Aims of the Committee

Further the academy’s mission of providing and promoting cutting edge and up to date research in cytopathology and publish in Acta Cytologica.

Responsibilities:

• Collaborate with WHO-IARC for publication of monographs as well as articles for Acta Cytologica.
• Establish training programs for junior faculty in basic and clinical research and statistical analysis.
• Identify potential topics (current and late breaking) and invite authors to submit their work to Acta Cytologica.
• Coordinate with the Communication committee for enhancing and promoting committee efforts

Dr. Lukas Bubendorf, MD, MIAC (Switzerland)

Professor Bubendorf is head of the Cytopathology Division at the Institute for Pathology of the University Hospital Basel, Basel, Switzerland.
His major interests and diagnostic expertise lie within lung pathology and uropathology, and in the general field of cytopathology. His research group currently investigates the role of genomic evolution and heterogeneity in solid tumors, including lung and prostate cancer. In cytology, he aims at translating molecular techniques and assays to clinical routine application

Dr. Claudio Bellevicine, MD, PhD, MIAC (Italy)

Claudio Bellevicine is Associate Professor of Anatomic Pathology at the University of Naples Federico II, Italy. He is a practicing cytopathologist with expertise in interventional procedures and molecular diagnostics, with a special focus on thyroid pathology. Prof. Bellevicine has authored over 150 peer-reviewed publications (Scopus, accessed June, 2025) and serves on the editorial review board of Cancer Cytopathology as well as the editorial boards of Cytopathology and the Journal of Molecular Pathology. He is a contributing chapter co-author to both the WHO Reporting System for Cytopathology and the Bethesda System for Reporting Thyroid Cytopathology.  

Dr. Haeryoung Kim, MD, MIAC (Korea)

Dr. Haeryoung Kim is a professor in the Department of Pathology at Seoul National University Hospital and Seoul National University College of Medicine. Her main area of expertise is liver and pancreaticobiliary pathology.  

Currently, she serves as Secretary General of the local organizing committee for the ICC 2028 in Suwon. She is currently the Editor-in-Chief of the Journal of Liver Cancer, an Associate Editor for the Journal of Pathology and Transnational Medicine, and serves on the editorial board of Clinical and Molecular Hepatology. 

Dr. Sinchita Roy Chowdhuri, MD, MIAC (USA)

Dr. Sinchita Roy-Chowdhuri is a Professor at The University of Texas MD Anderson Cancer Center (MDACC) in Houston, TX, board-certified in Molecular Pathology and Cytopathology.  Her research interests include biomarker testing, especially in non-small cell lung cancer, and the application of molecular diagnostics in cytopathology.  She has served as a section Editor for the WHO Blue book for Lung Cytopathology, and is co-Editor of the book Molecular Diagnostics in Cytopathology: A Practical handbook for the Practicing Pathologist. 

Dr. Michiya Nishino, MD, MIAC (USA)

Bio coming soon

dr. Syed Z. Ali, MD, FRCPath, FIAC (USA)

Prof. Ali serves as Professor of Pathology and Radiology at the Johns Hopkins University School of Medicine as well as the Director of the Division of Cytopathology at The Johns Hopkins Hospital. He received his Pathology residency training at North Shore University Hospital/Cornell University in New York with fellowships in Oncologic Surgical Pathology at Memorial Sloan-Kettering Cancer Center in New York and Cytopathology at The Johns Hopkins Hospital in Baltimore.

Known globally as an innovative educator, Prof. Ali has well over 375 invited lectures, keynote speeches and visiting professorships all over the world. In collaboration with international societies and universities, he directs or co-directs several annual major cytopathology tutorials.

Prof. Ali has published extensively with over 335 peer-reviewed articles in major scientific journals, over 35 books, book chapters and electronic media. Known for his expertise in “Thyroid” and “Pancreatic” cytopathology, his monograph on “The Bethesda System for Reporting Thyroid Cytopathology” (now in its 3rd edition) has been translated in 8 languages and is extensively used in medical practice all over the world. He is the founding editor-in-chief of the Journal of the American Society of Cytopathology (JASC) and a past-President of the American Society of Cytopathology (ASC). Presently, he serves as the President of the International Academy of Cytology (IAC) and Chair of the International Board of Cytopathology of the IAC. He is a fellow of both the Royal College of Pathologists (UK) and the IAC. He is recipient of the ASC’s “Warren R. Lang Award” in 1996, “President’s Award” in 2012, “Excellence in Education Award” in 2015, the IAC’s “Maurice Goldblatt Award” in 2019, Papanicolaou Society of Cytopathology’s “LC Tao Educator of the Year Award” in 2022 and the ASC’s “Papanicolaou Award” in 2023.

Massimo Bongiovanni, MD, FIAC (Switzerland)

Dr. Bongiovanni is head of Cytopathology at SYNLAB Pathology in Lausanne, Switzerland. He is member of the Pathology Expert Group, at SYNLAB International, Member (MIAC) and then Fellow (FIAC) of the International Academy of Cytology since 2016. He is the author of more than 200 scientific articles and 15 book chapters. He was Vice President of the Swiss Cytology Society (2015-2021) and a member of the Endocrine Tumor Group of the European Organisation for Research and Treatment of Cancer (EORTC). He is associate editor of the journal Acta Cytologica and participates in the editorial board of the journal Diagnostic Cytopathology. He is currently co-chair of the scientific committee of the European Federation of Cytology Societies (EFCS).